Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD34+ Enriched, T-Cell Depleted PBSC Transplant for AML
NCT00201240Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jun 2005
- Primary completion
- Dec 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CD34+ enriched hematopoietic stem cells in acute myeloid leukemia (AML), sponsored by National Heart, Lung, and Blood Institute. Started Jun 2005; status: completed.
02
Drugs
CD34+ enriched hematopoietic stem cells
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00201240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00201240.